发明人周伟,李文辉,郑宇鹏. "Method for the Synthesis of Vonoprazan Fumarate Impurity 30" [P]. 中国发明专利, 专利号 CN 112912822 A, 授权公告日 2015-06-14.
Johnson M A, Mueller T, Anderson J P. "A Process for Preparing High-Purity Vonoprazan Fumarate Impurity 30" [P]. US Patent, US 9574600 B2, 2025-11-04.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of 【停用请询:C4X-1020203】富马酸伏诺拉生杂质30 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2022, 2022, (4), 5770-5796.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of 【停用请询:C4X-1020203】富马酸伏诺拉生杂质30 as an Impurity". J. Chromatogr. A, 2012, 2429, (12), 7435-7439.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of Vonoprazan Fumarate Impurity 30 Using HRMS and NMR". Phytochemistry, 2024, 182, (5), 1186-1201.
Zhang Y, Li Q, Chen T. "Forced Degradation Studies to Evaluate 【停用请询:C4X-1020203】富马酸伏诺拉生杂质30 Profile in Drug Substances According to ICH Guidelines". Talanta, 2014, 2053, (7), 5727-5749.